Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Biomira selects PX-866 as clinical development candidate

Biomira selects PX-866 as clinical development candidate

Stanford brain tumor vaccine to be tested nationally

Stanford brain tumor vaccine to be tested nationally

Mayo Clinic tests engineered measles virus against multiple myeloma

Mayo Clinic tests engineered measles virus against multiple myeloma

Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme

Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme

New method for targeting malignant brain tumors

New method for targeting malignant brain tumors

NIH to map genomic changes of lung, brain, and ovarian cancers

NIH to map genomic changes of lung, brain, and ovarian cancers

Synthetic low-density lipoprotein-like nanoparticles target brain tumors

Synthetic low-density lipoprotein-like nanoparticles target brain tumors

Cancer stem cells spur glioma angiogenesis, could hold key to brain tumor therapy

Cancer stem cells spur glioma angiogenesis, could hold key to brain tumor therapy

Turning the immune system against cancer

Turning the immune system against cancer

New data show Enzastaurin's activity across multiple cancer cell lines

New data show Enzastaurin's activity across multiple cancer cell lines

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Promising chemo, therapeutic viruses, cutting-edge surgery debut at M. D. Anderson Cancer Center

Inflammation cuts both ways

Inflammation cuts both ways

Immune response protects against brain tumor development

Immune response protects against brain tumor development

Gene therapy treatment for brain tumours and infections

Gene therapy treatment for brain tumours and infections

Lilly launches phase III trial of Enzastaurin

Lilly launches phase III trial of Enzastaurin

Target identified for therapeutic drugs to fight adult brain cancer

Target identified for therapeutic drugs to fight adult brain cancer

Study suggests a way to eliminate glioblastoma

Study suggests a way to eliminate glioblastoma

Researchers can now identify patients likely to respond to cancer drug therapy

Researchers can now identify patients likely to respond to cancer drug therapy

Combination of radiotherapy and a drug named S247 as a cure for cancer

Combination of radiotherapy and a drug named S247 as a cure for cancer

EphA2 represents a promising treatment target for glioblastoma multiforme

EphA2 represents a promising treatment target for glioblastoma multiforme